Lombard Odier Selection - Healthcare Innovation
The Sub-Fund invests primarily in equity securities or equity-related securities issued by companies worldwide (including Emerging Markets) exercising a prominent part of their business activities in the healthcare industry. The Sub-Fund may (i) in normal market conditions and in accordance with the applicable diversification rules, hold on a temporary and ancillary basis up to 30% of its net assets in Cash and Cash Equivalents (including short-term ABS/MBS which may represent up to 10% of investments in Cash and Cash Equivalents) and (ii) hold up to 10% of its net assets in UCIs. The Sub-Fund may invest up to 20% of its net assets in shares issued by mainland China-incorporated companies (including China A-Shares) that trade on exchanges.
Entradas y salidas de dinero mensuales.